Home » Topics » BioWorld Science

BioWorld Science
RSS

Boehringer Ingelheim patents GluN2B negative allosteric modulators

July 2, 2019

SciFluor Life Sciences divulges KCNQ2/3 activators

July 2, 2019

Results from phase II study presented for sintilimab in patients with R/R ENKTL

July 2, 2019

Enrollment begins in phase III study of camrelizumab plus rivoceranib for HCC

July 2, 2019

First patient enrolled in phase II study of rimegepant for refractory trigeminal neuralgia

July 2, 2019

Cerecor announces promising final results from phase I study of CERC-301

July 2, 2019

First-in-human data presented for SRA-737

July 2, 2019

Hanmi presents phase I results for belvarafenib in patients with solid tumors

July 2, 2019

Results from phase II study of trabectedin in recurrent grade II or III meningioma

July 2, 2019

Goldfish genome brings zebrafish insight

July 2, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...